The Global Brain Computer Interface Market is estimated to be valued at USD 2.40 Bn in 2025 and is expected to reach USD 6.16 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 14.4% from ...
The ability to analyze the brain's neural connectivity is emerging as a key foundation for brain-computer interface (BCI) ...
US brain-computer-interface startup Paradromics is quickly establishing itself as a major player in the neural-device space, ...
Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.
Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...
Paradromics announced that it received FDA investigational device exemption (IDE) to begin a study of its brain-computer ...
Synchron successfully implanted the first FDA-approved brain-computer interface in a U.S. patient with ALS. The device ...
Check out snap DISCOVERY's latest hands-free, brain-to-computer interface and how the technology is shaping the future of ...
Neurotechnology company Paradromics will test its device in a trial aimed at safely restoring speech for people with severe motor impairments.
Late Wednesday evening, a CDC webpage that previously said there’s no link between autism and vaccines was quietly updated to ...